Evidence map›Paper›PMID 29704307›Full record

ArticleHuman mutation2018

MECP2 variation in Rett syndrome-An overview of current coverage of genetic and phenotype data within existing databases.

Gillian S Townend, Friederike Ehrhart, Henk J van Kranen, Mark Wilkinson, Annika Jacobsen, Marco Roos, Egon L Willighagen, David van Enckevort, Chris T Evelo, Leopold M G Curfs

Abstract read
In one paragraph

Article in Human mutation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Reciprocal regulation of the HbioRxiv : the preprint server for biology · 2025
    Article
  3. Sleep Disorders in Children with Rett Syndrome.Children (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Variant Profile of MECP2 Gene in Sri Lankan Patients with Rett Syndrome.Journal of autism and developmental disorders · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Novel advanced patient-derivedFrontiers in neurology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gillian S TownendRett Expertise Centre Netherlands - GKC, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0002-5448-9046
Friederike EhrhartRett Expertise Centre Netherlands - GKC, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0002-7770-620X
Henk J van KranenRett Expertise Centre Netherlands - GKC, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0001-7777-3245
Mark WilkinsonCenter for Plant Biotechnology and Genomics, Universidad Politécnica de Madrid, Madrid, Spain.ORCID 0000-0001-6960-357X
Annika JacobsenDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-4818-2360
Marco RoosDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-8691-772X
Egon L WillighagenDepartment of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, The Netherlands.
David van EnckevortDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-2440-3993
Chris T EveloRett Expertise Centre Netherlands - GKC, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0002-5301-3142
Leopold M G CurfsRett Expertise Centre Netherlands - GKC, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0001-9154-1395

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rett syndrome (RTT) is a monogenic rare disorder that causes severe neurological problems. In most cases, it results from a loss-of-function mutation in the gene encoding methyl-CPG-binding protein 2 (MECP2). Currently, about 900 unique MECP2 variations (benign and pathogenic) have been identified and it is suspected that the different mutations contribute to different levels of disease severity. For researchers and clinicians, it is important that genotype-phenotype information is available to identify disease-causing mutations for diagnosis, to aid in clinical management of the disorder, and to provide counseling for parents. In this study, 13 genotype-phenotype databases were surveyed for their general functionality and availability of RTT-specific MECP2 variation data. For each database, we investigated findability and interoperability alongside practical user functionality, and type and amount of genetic and phenotype data. The main conclusions are that, as well as being challenging to find these databases and specific MECP2 variants held within, interoperability is as yet poorly developed and requires effort to search across databases. Nevertheless, we found several thousand online database entries for MECP2 variations and their associated phenotypes, diagnosis, or predicted variant effects, which is a good starting point for researchers and clinicians who want to provide, annotate, and use the data.

Indexed as

Databases, GeneticFemaleGenotypeHumansLoss of Function MutationMaleMethyl-CpG-Binding Protein 2MutationPhenotypeRett SyndromeMECP2 protein, humanMethyl-CpG-Binding Protein 2databasesFAIR datagenetic variationMECP2phenotypeRett syndrome

Identifiers

PMID29704307
PMCPMC6033003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.